PMC:7102662 / 105-378 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T4","span":{"begin":6,"end":14},"obj":"Disease"},{"id":"T5","span":{"begin":85,"end":91},"obj":"Disease"},{"id":"T6","span":{"begin":174,"end":182},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"2019 (COVID-19) have underlying cardiovascular (CV) disease or develop acute cardiac injury during the course of the illness. Adequate understanding of the interplay between COVID-19 and CV disease is required for optimum management of these patients.\n\nMethods\nA literature"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":261,"end":262},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"2019 (COVID-19) have underlying cardiovascular (CV) disease or develop acute cardiac injury during the course of the illness. Adequate understanding of the interplay between COVID-19 and CV disease is required for optimum management of these patients.\n\nMethods\nA literature"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T5","span":{"begin":126,"end":251},"obj":"Sentence"},{"id":"T6","span":{"begin":253,"end":260},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"2019 (COVID-19) have underlying cardiovascular (CV) disease or develop acute cardiac injury during the course of the illness. Adequate understanding of the interplay between COVID-19 and CV disease is required for optimum management of these patients.\n\nMethods\nA literature"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T4","span":{"begin":6,"end":14},"obj":"SP_7"},{"id":"T5","span":{"begin":32,"end":46},"obj":"UBERON:0004535"},{"id":"T6","span":{"begin":77,"end":84},"obj":"UBERON:0000948"},{"id":"T7","span":{"begin":174,"end":182},"obj":"SP_7"},{"id":"T91319","span":{"begin":6,"end":14},"obj":"SP_7"},{"id":"T37138","span":{"begin":32,"end":46},"obj":"UBERON:0004535"},{"id":"T54318","span":{"begin":77,"end":84},"obj":"UBERON:0000948"},{"id":"T54869","span":{"begin":174,"end":182},"obj":"SP_7"}],"text":"2019 (COVID-19) have underlying cardiovascular (CV) disease or develop acute cardiac injury during the course of the illness. Adequate understanding of the interplay between COVID-19 and CV disease is required for optimum management of these patients.\n\nMethods\nA literature"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"13","span":{"begin":242,"end":250},"obj":"Species"},{"id":"15","span":{"begin":6,"end":14},"obj":"Disease"},{"id":"16","span":{"begin":32,"end":59},"obj":"Disease"},{"id":"17","span":{"begin":77,"end":91},"obj":"Disease"},{"id":"18","span":{"begin":174,"end":182},"obj":"Disease"},{"id":"19","span":{"begin":187,"end":197},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"tao:has_database_id","subj":"13","obj":"Tax:9606"},{"id":"A15","pred":"tao:has_database_id","subj":"15","obj":"MESH:C000657245"},{"id":"A16","pred":"tao:has_database_id","subj":"16","obj":"MESH:D002318"},{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"MESH:D006331"},{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"MESH:C000657245"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"MESH:D003141"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"2019 (COVID-19) have underlying cardiovascular (CV) disease or develop acute cardiac injury during the course of the illness. Adequate understanding of the interplay between COVID-19 and CV disease is required for optimum management of these patients.\n\nMethods\nA literature"}